Faes Farma logo

Faes Farma

Stock
Stock
ISIN: ES0134950F36
Ticker: FAE
ES0134950F36
FAE

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Faes Farma has so far distributed $0.147 in 2026. The next dividend will be paid on 12.01.2027


$0.11

CHART BY

Frequently asked questions

The market capitalization of Faes Farma is $1.65B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Faes Farma is 17.09. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Faes Farma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.31. EPS indicates the company's profitability on a per-share basis.
Currently, 5 analysts cover Faes Farma's stock, with a consensus target price of $6.051. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Faes Farma reported a revenue of $799.00M.
Faes Farma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $155.30M. EBITDA measures the company's overall financial performance.
Faes Farma has a free cash flow of $70.63M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
The free float of Faes Farma is 243.19M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.65B
EPS (TTM) 
$0.31
Free Float 
243.19M
P/E ratio (TTM) 
17.09
Revenue (TTM) 
$799.00M
EBITDA (TTM) 
$155.30M
Free Cashflow (TTM) 
$70.63M

Pricing

1D span
$5.234$5.373
52W span
$4.874$6.41

Analyst Ratings

The price target is $6.051 and the stock is covered by 5 analysts.

Buy

3

Hold

1

Sell

1

Information

Faes Farma SA operates as a pharmaceutical company. It engages in manufacturing and sale of chemical and pharmaceutical products, as well as the acquisition, purchase, sale, investment, holding, administration, management, negotiation and leasing of companies, of transferable and immovable securities, patents, trademarks and registrations and social participations. The company was founded in 1933 and is headquartered in Leioa, Spain.

Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
ES0134950F36
Primary Ticker
FAE

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation